U.S. Physical Therapy stock reports 8.5 percent Q2 growth

Published on 10/07/2026 at 02:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

U.S. Physical Therapy stock carries a USD 98.25 average analyst target from 7 analysts as of October 6, 2026. Q2 revenue rose 8.5 percent year over year.

USPH, US90337L1089, Illustration mit AI erstellt.

U.S. Physical Therapy (ISIN US90337L1089) generated USD 214.1 million in Q2 2026 revenue, an 8.5 percent increase from the prior-year quarter, according to Quartr on September 10, 2026. The results give U.S. Physical Therapy stock a clear operating-growth story, while profitability remains the key point for investors.

Revenue grows while earnings weaken

Quartr reported Q2 2026 net income attributable to shareholders of USD 9.9 million, down from USD 12.4 million in Q2 2025. Earnings per share was USD 0.25, compared with USD 0.58 in the year-earlier quarter.

The company reaffirmed adjusted EBITDA guidance of USD 102.0 million to USD 106.0 million for fiscal year 2026, according to Quartr. That range places execution and cost control alongside revenue growth as the central test for the second half of the year.

Clinic volume supports expansion

U.S. Physical Therapy recorded 1,661,694 visits in Q2 2026, up 6.6 percent year over year, while average daily visits per clinic reached 33.5, according to Quartr. The company integrated 31 clinics into hospital affiliations during the quarter and expected 39 additional integrations in Q3 2026.

The operating mix also matters: physical therapy revenue reached USD 182.4 million in Q2 2026, while industrial injury prevention revenue was USD 31.7 million, as reported by Quartr. Together, the segments provide volume growth, but the lower Q2 earnings figure shows that expansion has not yet translated into comparable profit growth.

Analysts set a higher bar

As of October 6, 2026, MarketBeat listed a Moderate Buy consensus from 7 analysts, with an average target of USD 98.25, a high of USD 102.00 and a low of USD 95.00. Against the October 6 price of USD 83.63, the average target stands 17.5 percent higher, so the market is pricing in further improvement beyond the Q2 earnings comparison.

USPH stays below its yearly high

USPH was last at USD 83.63 on the NYSE on October 6, 2026 at 4:00 p.m. ET, down 0.39 percent on the session. The price remained within its 52-week range of USD 58.19 to USD 93.50, while market capitalization stood at USD 1.3 billion as of October 6, 2026.